Available online at: https://www.gavi.org/vaccineswork/covid-19-vaccine-race [Last accessed: July 8, 2021]). Vaccine typeInstituteCountry Viral vector vaccine Beijing wantai biological pharmacy China Protein subunit vaccine West china hospital of sichuan university China RNA vaccine Arcturus/duke-...
While there has been progress in pre-clinical and clinical development of vaccines against LASV, there are currently no approved therapeutics or anti-viral drugs available for the treatment of LF. The high disease burden in West Africa, along with the logistical difficulties in deploying vaccines t...
Against the bleak backdrop of a dismal 2020 and a worsening pandemic, November finally gifted the world some good news: the Pfizer and Moderna Covid-19 vaccines were shockingly effective. We celebrated, a bit. Then the bickering began. How are we to distribute these vacci...
Current COVID-19 vaccines present the spike protein in very different ways to the immune system, and two main categories have to be discerned. The first category consists of mRNA and adenoviral vector vaccines (herein referred to as genetic vaccines, sections: “Genetic vaccines—general, “mRNA...
Table 7 Current list of available vaccines and their efficiency Full size table mRNA Vaccines BNT162b2 BNT162b2 mRNA-based vaccine was developed by the Pfizer BioNtech, Fousun pharma. BioNtech is the first company to register for the FDA approval of their candidate COVID-19 vaccine. BNT162b2...
smallpox or measles. This has contributed to an uneasy relationship between the lay public and stewards of public health. In a recent survey of pediatricians and family practitioners, 11% of the physicians did not recommend to parents that children receive all available vaccines.[2]Thus, controver...
On January 11, the United States reported a record-breaking 1.35 million new COVID-19 infections, shattering the previous record set just eight days before. The sky-high case rate—roughly four times higher than numbers of daily infections seen last Janu
Data from a survey of 343 oncologists from 28 countries with a self-reported COVID-19 outbreak (99.7%) reported that PPE was available to all participants (Ürün et al., 2020). It should be noted that the type of PPE used by the participating oncologists varied, and while 89.8% ...
enhance host immune response with the help of traditional Chinese medicine, which are observed quite effective against viral epidemics in past before effective vaccines were developed for the complete virus elimination so the implementation could be a hopeful contribution in COVID-19 therapeutic ...
How many people plan to take a COVID-19 vaccine? Our understanding is that the number of Americans who plan to refuse avaccinefor COVID-19, when it becomes available, is quite pervasive. Somewhere between 1 in 5 to1 in 3 Americansplan to refuse a vaccine depending on the survey and ho...